NCT03549494 2024-02-07
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Catalysis SL
Phase 2 Completed
Clinical Trials
7 trialsNCT05624099 2023-10-19
Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.
Fujian Cancer Hospital
Phase 2 Recruiting
NCT05252078 2022-12-16
ALTER-E005
Jiangxi Provincial Cancer Hospital
Phase 2 Recruiting
NCT04481100 2020-10-14
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT03187314 2020-08-17
Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
Hangzhou Cancer Hospital
Phase 2 Completed
NCT03200691 2017-08-07
Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT00442507 2015-07-24
OSI3650
Washington University School of Medicine
Phase 2 Terminated